181 related articles for article (PubMed ID: 7803523)
1. Clinical efficacy of gamma-hydroxybutyric acid in treatment of opiate withdrawal.
Gallimberti L; Schifano F; Forza G; Miconi L; Ferrara SD
Eur Arch Psychiatry Clin Neurosci; 1994; 244(3):113-4. PubMed ID: 7803523
[TBL] [Abstract][Full Text] [Related]
2. Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome.
Gallimberti L; Cibin M; Pagnin P; Sabbion R; Pani PP; Pirastu R; Ferrara SD; Gessa GL
Neuropsychopharmacology; 1993 Aug; 9(1):77-81. PubMed ID: 8397726
[TBL] [Abstract][Full Text] [Related]
3. Effects of gamma-hydroxybutyric acid (GHB) in opioid-dependent patients.
Rosen MI; Pearsall HR; Woods SW; Kosten TR
J Subst Abuse Treat; 1997; 14(2):149-54. PubMed ID: 9258859
[TBL] [Abstract][Full Text] [Related]
4. Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal.
Bearn J; Gossop M; Strang J
Drug Alcohol Depend; 1996 Dec; 43(1-2):87-91. PubMed ID: 8957147
[TBL] [Abstract][Full Text] [Related]
5. Fatality due to gamma-hydroxybutyric acid (GHB) and heroin intoxication.
Ferrara SD; Tedeschi L; Frison G; Rossi A
J Forensic Sci; 1995 May; 40(3):501-4. PubMed ID: 7782758
[TBL] [Abstract][Full Text] [Related]
6. [Hypernatremia caused by treatment with GHB obtained via a doctor's prescription].
Rood IM; Seijger CG; van Waarde JA; de Maat MM; Verhave JC; Blans MJ
Tijdschr Psychiatr; 2017; 59(1):47-51. PubMed ID: 28098924
[TBL] [Abstract][Full Text] [Related]
7. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.
Gallimberti L; Canton G; Gentile N; Ferri M; Cibin M; Ferrara SD; Fadda F; Gessa GL
Lancet; 1989 Sep; 2(8666):787-9. PubMed ID: 2571021
[TBL] [Abstract][Full Text] [Related]
8. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
[TBL] [Abstract][Full Text] [Related]
9. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses.
Leone MA; Vigna-Taglianti F; Avanzi G; Brambilla R; Faggiano F
Cochrane Database Syst Rev; 2010 Feb; (2):CD006266. PubMed ID: 20166080
[TBL] [Abstract][Full Text] [Related]
10. Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence.
Keating GM
Clin Drug Investig; 2014 Jan; 34(1):63-80. PubMed ID: 24307430
[TBL] [Abstract][Full Text] [Related]
11. [Drug substitution in heroin dependence with methadone].
Krausz M; Raschke P; Naber D
Internist (Berl); 1999 Jun; 40(6):645-50. PubMed ID: 10420320
[No Abstract] [Full Text] [Related]
12. Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence.
Mannucci C; Pichini S; Spagnolo EV; Calapai F; Gangemi S; Navarra M; Calapai G
Curr Drug Metab; 2018; 19(13):1056-1064. PubMed ID: 29219048
[TBL] [Abstract][Full Text] [Related]
13. Two cases of clonidine abuse/dependence in methadone-maintained patients.
Lauzon P
J Subst Abuse Treat; 1992; 9(2):125-7. PubMed ID: 1512800
[TBL] [Abstract][Full Text] [Related]
14. Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.
Umbricht A; Hoover DR; Tucker MJ; Leslie JM; Chaisson RE; Preston KL
Drug Alcohol Depend; 2003 Apr; 69(3):263-72. PubMed ID: 12633912
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of gamma-hydroxybutyrate withdrawal].
Strand NAW; Petersen TS; Nielsen LM; Boegevig S
Ugeskr Laeger; 2017 Dec; 179(50):. PubMed ID: 29260701
[TBL] [Abstract][Full Text] [Related]
16. Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal.
Miotto K; Darakjian J; Basch J; Murray S; Zogg J; Rawson R
Am J Addict; 2001; 10(3):232-41. PubMed ID: 11579621
[TBL] [Abstract][Full Text] [Related]
17. [Withdrawal syndrome following chronic use of gamma-hydroxybutyric acid (GHB)].
Moitroux A; Kestens C
Rev Med Liege; 2023 Jul; 78(7-8):451-455. PubMed ID: 37560960
[TBL] [Abstract][Full Text] [Related]
18. Craving and drug reward: a comparison of methadone and clonidine in detoxifying opiate addicts.
Dawe S; Gray JA
Drug Alcohol Depend; 1995 Oct; 39(3):207-12. PubMed ID: 8556969
[TBL] [Abstract][Full Text] [Related]
19. The gamma-hydroxybutyrate withdrawal syndrome.
Tarabar AF; Nelson LS
Toxicol Rev; 2004; 23(1):45-9. PubMed ID: 15298492
[TBL] [Abstract][Full Text] [Related]
20. Medical mismanagement in public methadone programs.
Blansfield HN
Conn Med; 1994 Mar; 58(3):161-4. PubMed ID: 8039380
[No Abstract] [Full Text] [Related]
[Next] [New Search]
